HEADER BLOOD CLOTTING 22-DEC-99 1C5Y TITLE STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- TITLE 2 MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (UROKINASE-TYPE PLASMINOGEN ACTIVATOR); COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: SHORT CHAIN; COMPND 5 EC: 3.4.21.73; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PROTEIN (UROKINASE-TYPE PLASMINOGEN ACTIVATOR); COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: CATALYTIC DOMAIN; COMPND 11 EC: 3.4.21.73; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HISTIDINE DEFICIENT GS115; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PPIC9; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: HISTIDINE DEFICIENT GS115; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PPIC9 KEYWDS SELECTIVE, S1 SITE INHIBITOR, STRUCTURE-BASED DRUG DESIGN, UROKINASE, KEYWDS 2 TRYPSIN, THROMBIN, BLOOD CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR B.A.KATZ,R.MACKMAN,C.LUONG,K.RADIKA,A.MARTELLI,P.A.SPRENGELER,J.WANG, AUTHOR 2 H.CHAN,L.WONG REVDAT 6 03-APR-24 1C5Y 1 REMARK REVDAT 5 27-DEC-23 1C5Y 1 REMARK SEQADV REVDAT 4 04-OCT-17 1C5Y 1 REMARK REVDAT 3 24-FEB-09 1C5Y 1 VERSN REVDAT 2 26-SEP-01 1C5Y 3 ATOM REVDAT 1 22-DEC-00 1C5Y 0 JRNL AUTH B.A.KATZ,R.MACKMAN,C.LUONG,K.RADIKA,A.MARTELLI, JRNL AUTH 2 P.A.SPRENGELER,J.WANG,H.CHAN,L.WONG JRNL TITL STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, JRNL TITL 2 S1-BINDING, SUBMICROMOLAR INHIBITOR OF UROKINASE-TYPE JRNL TITL 3 PLASMINOGEN ACTIVATOR. JRNL REF CHEM.BIOL. V. 7 299 2000 JRNL REFN ISSN 1074-5521 JRNL PMID 10779411 JRNL DOI 10.1016/S1074-5521(00)00104-6 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.900 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 67.9 REMARK 3 NUMBER OF REFLECTIONS : 19808 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : X-PLOR REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1963 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.72 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 32.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1014 REMARK 3 BIN R VALUE (WORKING SET) : 0.4100 REMARK 3 BIN FREE R VALUE : 0.4490 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 140 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2029 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 51 REMARK 3 SOLVENT ATOMS : 349 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.018 REMARK 3 BOND ANGLES (DEGREES) : 4.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.430 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : UPA7538_PARMALLH3X.PRO REMARK 3 PARAMETER FILE 2 : UPA7538_PARAM11_UCSF.WAT REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : UPA7538_TOPALLH6X.PRO REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 BULK SOLVENT TERMS INCLUDED IN FOB FILE CREATED WITH STANDARD X- REMARK 3 PLOR SCRIPT. REMARK 3 ONLY LEU A9 TO THR_A17 ARE INCLUDED FOR THE A-CHAIN. REMARK 3 RESIDUES PRIOR AND AFTER THESE RESIDUES ARE NOT VISIBLE REMARK 3 (DISORDERED). REMARK 3 RESIDUES AFTER GLU_B245 ARE NOT VISIBLE (DISORDERED). REMARK 3 DENSITY FOR LYS_B243 THROUGH GLU_B245 IS WEAK OR ABSENT REMARK 3 REMARK 3 RESIDUES SIMULTANEOUSLY REFINED IN TWO OR MORE CONFORMATIONS ARE: REMARK 3 ILE_B17, MET_B47, MET_B81, GLU_B84, GLU_B86, LEU_B123, THR_B139, REMARK 3 ARG_B166, GLN_B192, SER_B232, LEU_B235, THE INHIBITOR (246). REMARK 3 REMARK 3 NO ENERGY TERMS BETWEEN CITRATE 1 AND 2 ARE INCLUDED BECAUSE THEY REMARK 3 APPEAR REMARK 3 TO BE HYDROGEN-BONDED TO ONE ANOTHER VIA AN UNUSUALLY SHORT REMARK 3 HYDROGEN BOND REMARK 3 BETWEEN CARBOXYLATE GROUPS. REMARK 3 REMARK 3 DISORDERED WATERS ARE: REMARK 3 HOH75 WHICH IS CLOSE TO HOH76; REMARK 3 HOH247 WHICH IS CLOSE TO A SYMMETRY-RELATED EQUIVALENT REMARK 3 OF HOH248 WHICH IN TURN IS CLOSE TO HOH249; REMARK 3 HOH104 WHICH IS CLOSE TO HOH105; REMARK 3 HOH155 WHICH IS CLOSE TO CONFORMATION 1 OF GLU_B84; REMARK 3 HOH292 WHICH IS CLOSE TO HOH298; REMARK 3 HOH373 WHICH IS CLOSE TO HOH374; REMARK 3 HOH715 WHICH IS CLOSE TO HOH720 WHICH IN TURN IS CLOSE TO HOH721; REMARK 3 HOH598 WHICH IS CLOSE TO HOH831; REMARK 3 HOH70 WHICH IS CLOSE TO HOH364; REMARK 3 HOH401 WHICH IS CLOSE TO HOH846; REMARK 3 HOH462 WHICH IS CLOSE TO HOH465; REMARK 3 HOH451 WHICH IS CLOSE TO HOH719; REMARK 3 HOH423 WHICH IS CLOSE TO HOH429; REMARK 3 HOH358 WHICH IS CLOSE TO HOH910; REMARK 3 HOH30 WHICH IS CLOSE TO A SYMMETRY-RELATED EQUIVALENT OF ITSELF; REMARK 3 HOH25 WHICH IS CLOSE TO A SYMMETRY-RELATED EQUIVALENT OF HOH318; REMARK 3 HOH38 WHICH IS CLOSE TO A SYMMETRY-RELATED EQUIVALENT OF HOH694; REMARK 3 HOH146 WHICH IS CLOSE TO A SYMMETRY-RELATED EQUIVALENT OF HOH375; REMARK 3 HOH17 WHICH IS CLOSE TO A SYMMETRY-RELATED EQUIVALENT OF HOH82. REMARK 4 REMARK 4 1C5Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JAN-00. REMARK 100 THE DEPOSITION ID IS D_1000001378. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JUL-99 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MSC MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : BIOTEX (MSC) REMARK 200 DATA SCALING SOFTWARE : BIOTEX REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : 1.440 REMARK 200 RESOLUTION RANGE LOW (A) : 31.260 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.800 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 68.0 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : 0.08700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.72 REMARK 200 COMPLETENESS FOR SHELL (%) : 32.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.25500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIFFERENCE FOURIER PLUS REMARK 200 REFINEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: PDB1LMW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 25.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: LMW HUMAN UPA/A145 WAS CONCENTRATED TO REMARK 280 10 MG/ML AND INCUBATED IN 50 MM HEPES, 5.0 MM NACL. PH 7.0, 5.0 REMARK 280 MM THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDINE FOR 15 MIN ON ICE. THE REMARK 280 COMPLEX WAS CRYSTALLIZED BY VAPOR DIFFUSION IN HANGING DROPS REMARK 280 CONTAINING EQUAL VOLUMES OF PROTEIN-INHIBITOR SOLUTION (0.28 MM REMARK 280 UPA/A145, 1.4 MM INHIBITOR AND WELL SOLUTION (20 % 2-PROPANOL, REMARK 280 20 % PEG 4K, 100 MM SODIUM CITRATE, PH 6.5) SEALED OVER THE WELL. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 41.03500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.78500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 41.03500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.78500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 1 REMARK 465 PRO A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 PRO A 5 REMARK 465 PRO A 6 REMARK 465 GLU A 7 REMARK 465 GLU A 8 REMARK 465 LEU A 18 REMARK 465 ARG A 19 REMARK 465 PRO A 20 REMARK 465 ARG A 21 REMARK 465 PHE A 22 REMARK 465 LYS A 23 REMARK 465 ASN B 246 REMARK 465 GLY B 247 REMARK 465 LEU B 248 REMARK 465 ALA B 249 REMARK 465 LEU B 250 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 GLU B 244 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG B 37A NE CZ NH1 NH2 REMARK 480 GLN B 78 CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H1 HOH B 372 H2 HOH B 474 1.08 REMARK 500 HZ1 LYS B 92 HE1 TRP B 237 1.29 REMARK 500 HH11 ARG B 217 H2 HOH B 378 1.34 REMARK 500 H1 HOH B 288 O HOH B 589 1.37 REMARK 500 O HOH B 372 H2 HOH B 474 1.40 REMARK 500 O HOH B 266 H1 HOH B 403 1.41 REMARK 500 O HOH B 376 H2 HOH B 495 1.44 REMARK 500 O HOH B 385 H1 HOH B 479 1.45 REMARK 500 H2 HOH B 478 O HOH B 508 1.49 REMARK 500 H1 HOH B 351 O HOH B 354 1.50 REMARK 500 OG1 THR B 77 H2 HOH B 509 1.52 REMARK 500 O HOH B 373 H2 HOH B 582 1.53 REMARK 500 OG SER B 37D H2 HOH B 370 1.53 REMARK 500 O SER B 135 H1 HOH B 402 1.55 REMARK 500 OG SER B 75 H1 HOH B 537 1.56 REMARK 500 O ALA B 221 H1 HOH B 449 1.56 REMARK 500 O TYR B 64 H1 HOH B 502 1.57 REMARK 500 O SER B 75 H1 HOH B 509 1.57 REMARK 500 O HOH B 322 H1 HOH B 545 1.58 REMARK 500 O HOH B 458 H2 HOH B 547 1.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 H1 HOH B 385 H1 HOH B 388 3545 1.29 REMARK 500 H2 HOH B 320 H1 HOH B 480 3545 1.33 REMARK 500 H2 HOH B 418 O HOH B 462 4556 1.42 REMARK 500 H1 HOH B 542 O HOH B 543 4556 1.45 REMARK 500 H2 HOH B 320 O HOH B 480 3545 1.47 REMARK 500 H1 HOH B 418 O HOH B 541 4556 1.48 REMARK 500 O HOH B 352 H2 HOH B 353 2555 1.55 REMARK 500 O PRO B 185A H1 HOH B 305 4546 1.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS B 57 NE2 HIS B 57 CD2 -0.068 REMARK 500 HIS B 165 CG HIS B 165 CD2 0.055 REMARK 500 HIS B 170B CG HIS B 170B CD2 0.063 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TRP B 29 CG - CD1 - NE1 ANGL. DEV. = -6.1 DEGREES REMARK 500 TRP B 29 CD1 - NE1 - CE2 ANGL. DEV. = 8.1 DEGREES REMARK 500 TRP B 29 NE1 - CE2 - CZ2 ANGL. DEV. = 8.5 DEGREES REMARK 500 ARG B 35 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 ARG B 36 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 ARG B 37A N - CA - C ANGL. DEV. = -17.7 DEGREES REMARK 500 TRP B 51 CG - CD1 - NE1 ANGL. DEV. = -6.1 DEGREES REMARK 500 TRP B 51 CD1 - NE1 - CE2 ANGL. DEV. = 8.2 DEGREES REMARK 500 TRP B 51 NE1 - CE2 - CZ2 ANGL. DEV. = 9.5 DEGREES REMARK 500 TRP B 51 NE1 - CE2 - CD2 ANGL. DEV. = -6.2 DEGREES REMARK 500 ARG B 70 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 ARG B 72 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 ARG B 109 NE - CZ - NH2 ANGL. DEV. = -5.0 DEGREES REMARK 500 ARG B 116 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 ASP B 129 CB - CG - OD1 ANGL. DEV. = -5.7 DEGREES REMARK 500 ARG B 166 NE - CZ - NH2 ANGL. DEV. = -4.5 DEGREES REMARK 500 TRP B 186 CG - CD1 - NE1 ANGL. DEV. = -6.2 DEGREES REMARK 500 TRP B 186 CD1 - NE1 - CE2 ANGL. DEV. = 7.9 DEGREES REMARK 500 TRP B 186 NE1 - CE2 - CZ2 ANGL. DEV. = 7.5 DEGREES REMARK 500 LEU B 199 N - CA - C ANGL. DEV. = -19.5 DEGREES REMARK 500 CYS B 201 CA - CB - SG ANGL. DEV. = 6.8 DEGREES REMARK 500 ARG B 206 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 TRP B 215 CG - CD1 - NE1 ANGL. DEV. = -6.0 DEGREES REMARK 500 TRP B 215 CD1 - NE1 - CE2 ANGL. DEV. = 7.8 DEGREES REMARK 500 TRP B 215 NE1 - CE2 - CZ2 ANGL. DEV. = 7.2 DEGREES REMARK 500 TRP B 237 CG - CD1 - NE1 ANGL. DEV. = -6.3 DEGREES REMARK 500 TRP B 237 CD1 - NE1 - CE2 ANGL. DEV. = 8.3 DEGREES REMARK 500 TRP B 237 NE1 - CE2 - CZ2 ANGL. DEV. = 6.9 DEGREES REMARK 500 ARG B 239 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR B 22 -164.13 -129.77 REMARK 500 GLN B 27 58.37 -145.06 REMARK 500 VAL B 41 -70.00 -113.74 REMARK 500 SER B 54 -154.82 -149.80 REMARK 500 PRO B 60C 44.85 -76.82 REMARK 500 ASP B 93 12.41 101.99 REMARK 500 ASP B 97 -159.56 -131.05 REMARK 500 LEU B 97B -69.04 154.77 REMARK 500 MET B 126 112.95 -32.91 REMARK 500 TYR B 127 29.47 46.71 REMARK 500 TYR B 171 -107.71 -116.73 REMARK 500 TRP B 186 48.59 33.70 REMARK 500 SER B 214 -61.03 -123.38 REMARK 500 GLU B 244 -161.30 34.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FLC B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FLC B 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FLC B 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ESP B 251 DBREF 1C5Y A 1 23 UNP P00749 UROK_HUMAN 156 178 DBREF 1C5Y B 16 250 UNP P00749 UROK_HUMAN 179 431 SEQADV 1C5Y ALA B 145 UNP P00749 ASN 322 CONFLICT SEQRES 1 A 23 LYS PRO SER SER PRO PRO GLU GLU LEU LYS PHE GLN CYS SEQRES 2 A 23 GLY GLN LYS THR LEU ARG PRO ARG PHE LYS SEQRES 1 B 253 ILE ILE GLY GLY GLU PHE THR THR ILE GLU ASN GLN PRO SEQRES 2 B 253 TRP PHE ALA ALA ILE TYR ARG ARG HIS ARG GLY GLY SER SEQRES 3 B 253 VAL THR TYR VAL CYS GLY GLY SER LEU MET SER PRO CYS SEQRES 4 B 253 TRP VAL ILE SER ALA THR HIS CYS PHE ILE ASP TYR PRO SEQRES 5 B 253 LYS LYS GLU ASP TYR ILE VAL TYR LEU GLY ARG SER ARG SEQRES 6 B 253 LEU ASN SER ASN THR GLN GLY GLU MET LYS PHE GLU VAL SEQRES 7 B 253 GLU ASN LEU ILE LEU HIS LYS ASP TYR SER ALA ASP THR SEQRES 8 B 253 LEU ALA HIS HIS ASN ASP ILE ALA LEU LEU LYS ILE ARG SEQRES 9 B 253 SER LYS GLU GLY ARG CYS ALA GLN PRO SER ARG THR ILE SEQRES 10 B 253 GLN THR ILE CYS LEU PRO SER MET TYR ASN ASP PRO GLN SEQRES 11 B 253 PHE GLY THR SER CYS GLU ILE THR GLY PHE GLY LYS GLU SEQRES 12 B 253 ALA SER THR ASP TYR LEU TYR PRO GLU GLN LEU LYS MET SEQRES 13 B 253 THR VAL VAL LYS LEU ILE SER HIS ARG GLU CYS GLN GLN SEQRES 14 B 253 PRO HIS TYR TYR GLY SER GLU VAL THR THR LYS MET LEU SEQRES 15 B 253 CYS ALA ALA ASP PRO GLN TRP LYS THR ASP SER CYS GLN SEQRES 16 B 253 GLY ASP SER GLY GLY PRO LEU VAL CYS SER LEU GLN GLY SEQRES 17 B 253 ARG MET THR LEU THR GLY ILE VAL SER TRP GLY ARG GLY SEQRES 18 B 253 CYS ALA LEU LYS ASP LYS PRO GLY VAL TYR THR ARG VAL SEQRES 19 B 253 SER HIS PHE LEU PRO TRP ILE ARG SER HIS THR LYS GLU SEQRES 20 B 253 GLU ASN GLY LEU ALA LEU HET FLC B 1 18 HET FLC B 2 18 HET FLC B 3 18 HET ESP B 251 32 HETNAM FLC CITRATE ANION HETNAM ESP THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDINE FORMUL 3 FLC 3(C6 H5 O7 3-) FORMUL 6 ESP C8 H8 N3 S 1+ FORMUL 7 HOH *349(H2 O) HELIX 1 1 THR B 23 GLN B 27 5 5 HELIX 2 2 ALA B 55 PHE B 59 5 5 HELIX 3 4 SER B 164 GLN B 169 1 6 HELIX 4 5 TYR B 172 VAL B 176 5 5 HELIX 5 6 PHE B 234 THR B 242 1 9 SHEET 1 A 7 PHE B 30 ARG B 36 0 SHEET 2 A 7 VAL B 38 SER B 48 -1 O THR B 39 N ARG B 35 SHEET 3 A 7 TRP B 51 SER B 54 -1 O TRP B 51 N MET B 47 SHEET 4 A 7 ALA B 104 ARG B 109 -1 O ALA B 104 N SER B 54 SHEET 5 A 7 MET B 81 LEU B 90 -1 N GLU B 84 O ARG B 109 SHEET 6 A 7 TYR B 64 LEU B 68 -1 O TYR B 64 N VAL B 85 SHEET 7 A 7 PHE B 30 ARG B 36 -1 O ALA B 32 N TYR B 67 SHEET 1 B 2 SER B 95 ALA B 96 0 SHEET 2 B 2 HIS B 99 HIS B 100 -1 N HIS B 100 O SER B 95 SSBOND 1 CYS A 13 CYS B 122 1555 1555 2.01 SSBOND 2 CYS B 42 CYS B 58 1555 1555 2.01 SSBOND 3 CYS B 50 CYS B 111 1555 1555 2.02 SSBOND 4 CYS B 136 CYS B 201 1555 1555 2.01 SSBOND 5 CYS B 168 CYS B 182 1555 1555 2.00 SSBOND 6 CYS B 191 CYS B 220 1555 1555 2.02 SITE 1 AC1 9 TYR B 67 LYS B 82 SER B 164 HIS B 165 SITE 2 AC1 9 ARG B 166 HOH B 276 HOH B 400 HOH B 529 SITE 3 AC1 9 HOH B 534 SITE 1 AC2 8 ARG B 36 LYS B 82 LYS B 110A HIS B 165 SITE 2 AC2 8 ARG B 230 HOH B 400 HOH B 498 HOH B 534 SITE 1 AC3 12 HIS B 57 HIS B 99 GLN B 192 GLY B 193 SITE 2 AC3 12 SER B 195 ESP B 251 HOH B 285 HOH B 406 SITE 3 AC3 12 HOH B 489 HOH B 560 HOH B 561 HOH B 562 SITE 1 AC4 12 FLC B 3 ASP B 189 SER B 190 GLN B 192 SITE 2 AC4 12 SER B 195 TRP B 215 GLY B 216 GLY B 219 SITE 3 AC4 12 CYS B 220 GLY B 226 HOH B 485 HOH B 487 CRYST1 82.070 49.570 66.320 90.00 113.20 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012185 0.000000 0.005222 0.00000 SCALE2 0.000000 0.020173 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016405 0.00000